186:@0.017061:0.038809:0.056572:0.038809:0.056572:0.019212:0.017061:0.019212:0.013170:0.013170:0.013170
HANDBOOK OF ONCOLOGY:@0.084848:0.970015:0.320957:0.970015:0.320957:0.956010:0.084848:0.956010:0.011682:0.012657:0.012657:0.012726:0.009818:0.014864:0.014864:0.010109:0.004738:0.014864:0.008296:0.004738:0.014864:0.012657:0.013906:0.014864:0.007902:0.014864:0.014915:0.010126
type I INFs.  Type I IFNs bind to type I inter-:@0.084848:0.079499:0.475729:0.079499:0.475729:0.063743:0.084848:0.063743:0.006331:0.010122:0.012931:0.012315:0.005927:0.004156:0.005927:0.004156:0.014047:0.009140:0.007274:0.005330:0.012023:0.005927:0.008095:0.010122:0.012931:0.012315:0.005927:0.004156:0.005927:0.004156:0.009140:0.014047:0.007274:0.005927:0.012931:0.003656:0.011545:0.012989:0.005927:0.006331:0.012411:0.005927:0.006331:0.010122:0.012931:0.012315:0.005927:0.004156:0.005927:0.003656:0.011545:0.006331:0.012315:0.005600:0.006388
42:@0.182316:0.073880:0.194634:0.073880:0.194634:0.064694:0.182316:0.064694:0.006103:0.006215
feron receptors, which in turn activate cer-:@0.084844:0.095189:0.475762:0.095189:0.475762:0.079433:0.084844:0.079433:0.005850:0.012315:0.005519:0.012411:0.011545:0.005330:0.005521:0.012315:0.012257:0.012315:0.012931:0.006331:0.012411:0.005600:0.007274:0.005138:0.005330:0.015798:0.011545:0.003656:0.012257:0.011545:0.005330:0.003656:0.011545:0.005330:0.006331:0.011507:0.005998:0.011545:0.005330:0.012950:0.012257:0.006331:0.003656:0.010468:0.012950:0.006331:0.012315:0.005330:0.012257:0.012315:0.005600:0.006388
tain tyrosine kinase receptors.:@0.084844:0.110879:0.367030:0.110879:0.367030:0.095123:0.084844:0.095123:0.006331:0.012950:0.003656:0.011545:0.009679:0.006331:0.010122:0.005521:0.012411:0.007274:0.003656:0.011545:0.012315:0.009679:0.009467:0.003656:0.011545:0.012950:0.007274:0.012315:0.009679:0.005521:0.012315:0.012257:0.012315:0.012931:0.006331:0.012411:0.005600:0.007274:0.005330
42-45:@0.366816:0.105252:0.394952:0.105252:0.394952:0.096066:0.366816:0.096066:0.006103:0.006103:0.003612:0.006103:0.006215
. Activa-:@0.394849:0.110871:0.475763:0.110871:0.475763:0.095115:0.394849:0.095115:0.005138:0.009679:0.014047:0.012257:0.006331:0.003656:0.010468:0.012950:0.006388
tion of the tyrosine kinase receptors leads :@0.084853:0.126561:0.481132:0.126561:0.481132:0.110805:0.084853:0.110805:0.006331:0.003656:0.012411:0.011545:0.007639:0.012411:0.005850:0.007639:0.006331:0.011545:0.012315:0.007639:0.006331:0.010122:0.005521:0.012411:0.007274:0.003656:0.011545:0.012315:0.007639:0.009467:0.003656:0.011545:0.012950:0.007274:0.012315:0.007639:0.005521:0.012315:0.012257:0.012315:0.012931:0.006331:0.012411:0.005600:0.007274:0.007639:0.003656:0.012315:0.012950:0.012989:0.007470:0.005330
to enhanced activation of CD8-positive T-:@0.084853:0.142251:0.475801:0.142251:0.475801:0.126495:0.084853:0.126495:0.006331:0.012411:0.006850:0.012315:0.011545:0.011545:0.012950:0.011545:0.012257:0.012315:0.012989:0.006850:0.012950:0.012257:0.006331:0.003656:0.010468:0.012950:0.006331:0.003656:0.012411:0.011545:0.006850:0.012411:0.005850:0.006850:0.015452:0.014124:0.010468:0.006196:0.012931:0.012411:0.007274:0.003656:0.006331:0.003656:0.010468:0.012315:0.006850:0.008005:0.006388
cells that are the precursors for cytotoxic T-:@0.084853:0.157940:0.475759:0.157940:0.475759:0.142184:0.084853:0.142184:0.012257:0.012315:0.003656:0.003656:0.007274:0.005407:0.006331:0.011545:0.012950:0.006331:0.005407:0.012950:0.005521:0.012315:0.005407:0.006331:0.011545:0.012315:0.005407:0.012931:0.005521:0.012315:0.012257:0.011507:0.005600:0.007274:0.012411:0.005600:0.007274:0.005407:0.005850:0.012411:0.005600:0.005407:0.012257:0.010122:0.006331:0.012411:0.006331:0.012411:0.009044:0.003656:0.012257:0.005407:0.008005:0.006388
lymphocytes, activation of macrophages :@0.084853:0.173630:0.481114:0.173630:0.481114:0.157874:0.084853:0.157874:0.003656:0.010122:0.017857:0.012931:0.011545:0.012411:0.012257:0.010122:0.006331:0.012315:0.007274:0.005138:0.009063:0.012950:0.012257:0.006331:0.003656:0.010468:0.012950:0.006331:0.003656:0.012411:0.011545:0.009063:0.012411:0.005850:0.009063:0.017857:0.012950:0.012257:0.005521:0.012411:0.012931:0.011545:0.012950:0.012758:0.012315:0.007470:0.005330
and natural killer cells and upregulating of :@0.084853:0.189320:0.481070:0.189320:0.481070:0.173564:0.084853:0.173564:0.012950:0.011545:0.012989:0.006331:0.011545:0.012950:0.006331:0.011507:0.005600:0.012950:0.003656:0.006331:0.009467:0.003656:0.003656:0.003656:0.012315:0.005600:0.006331:0.012257:0.012315:0.003656:0.003656:0.007274:0.006331:0.012950:0.011545:0.012989:0.006331:0.011507:0.012931:0.005521:0.012315:0.012758:0.011507:0.003656:0.012950:0.006331:0.003656:0.011545:0.012758:0.006331:0.012411:0.006040:0.005330
MHC expression.:@0.084853:0.205010:0.235498:0.205010:0.235498:0.189254:0.084853:0.189254:0.017491:0.012950:0.015452:0.005138:0.012315:0.009044:0.012931:0.005519:0.012315:0.007274:0.007274:0.003656:0.012411:0.011545:0.005330
42-45:@0.235300:0.199368:0.263436:0.199368:0.263436:0.190182:0.235300:0.190182:0.006103:0.006103:0.003612:0.006103:0.006215
The best clinical responses of type I IFNs :@0.103030:0.220673:0.481105:0.220673:0.481105:0.204917:0.103030:0.204917:0.007774:0.011315:0.012084:0.008351:0.012700:0.012084:0.007043:0.006100:0.008351:0.012027:0.003425:0.003425:0.011315:0.003425:0.012027:0.012719:0.003425:0.008351:0.005288:0.012084:0.007043:0.012700:0.012180:0.011315:0.007043:0.012084:0.007043:0.008351:0.012180:0.005619:0.008351:0.006100:0.009891:0.012700:0.012084:0.008351:0.003925:0.008351:0.003925:0.008909:0.013816:0.007470:0.005330
are observed mainly, but not exclusively, in :@0.084846:0.236363:0.481101:0.236363:0.481101:0.220607:0.084846:0.220607:0.012719:0.005290:0.012084:0.006600:0.012180:0.012700:0.007043:0.012084:0.005369:0.010237:0.012084:0.012758:0.006600:0.017626:0.012719:0.003425:0.011315:0.003425:0.009891:0.004907:0.006600:0.012700:0.011276:0.006100:0.006600:0.011315:0.012180:0.006100:0.006600:0.012084:0.008813:0.012027:0.003425:0.011276:0.007043:0.003425:0.010237:0.012084:0.003425:0.009891:0.004907:0.006600:0.003425:0.011736:0.005330
haematological malignancies and cancers :@0.084846:0.252052:0.481070:0.252052:0.481070:0.236296:0.084846:0.236296:0.011315:0.012719:0.012084:0.017626:0.012719:0.006100:0.012180:0.003425:0.012180:0.012527:0.003425:0.012027:0.012719:0.003425:0.005657:0.017626:0.012719:0.003425:0.003425:0.012527:0.011315:0.012719:0.011315:0.012027:0.003425:0.012084:0.007043:0.005657:0.012719:0.011315:0.012758:0.005657:0.012027:0.012719:0.011315:0.012027:0.012084:0.005369:0.007470:0.005330
linked to viral infections.  Until the discovery :@0.084846:0.267742:0.481089:0.267731:0.481089:0.251975:0.084846:0.251986:0.003425:0.003425:0.011315:0.009236:0.012084:0.012758:0.005407:0.006100:0.012180:0.005407:0.010237:0.003425:0.005369:0.012719:0.003425:0.005407:0.003425:0.011315:0.005619:0.012084:0.012027:0.006100:0.003425:0.012180:0.011315:0.007043:0.005330:0.011526:0.005407:0.012180:0.011315:0.006100:0.003425:0.003425:0.005407:0.006100:0.011315:0.012084:0.005407:0.012758:0.003425:0.007043:0.012027:0.012180:0.010237:0.012084:0.005369:0.010318:0.612277
42:@0.296213:0.262112:0.308396:0.262112:0.308396:0.252926:0.296213:0.252926:0.005968:0.006215
of tyrosine kinase inhibitors (TKIs), INF-  was :@0.084846:0.283421:0.481070:0.283421:0.481070:0.267665:0.084846:0.267665:0.012180:0.005619:0.007947:0.006100:0.009891:0.005290:0.012180:0.007043:0.003425:0.011315:0.012084:0.007947:0.009236:0.003425:0.011315:0.012719:0.007043:0.012084:0.007947:0.003425:0.011315:0.011315:0.003425:0.012700:0.003425:0.006100:0.012180:0.005369:0.007043:0.007947:0.006677:0.007774:0.010949:0.003925:0.007043:0.006677:0.004907:0.007947:0.003925:0.013816:0.008909:0.006388:0.009219:0.007947:0.015567:0.012719:0.007470:0.005330
α:@0.422394:0.285273:0.432458:0.285273:0.432458:0.267427:0.422394:0.267427:0.010064
the treatment of choice in CML and is  indi-:@0.084846:0.299110:0.475792:0.299110:0.475792:0.283354:0.084846:0.283354:0.006100:0.011315:0.012084:0.005657:0.006100:0.005290:0.012084:0.012719:0.006100:0.017626:0.012084:0.011315:0.006100:0.005657:0.012180:0.005619:0.005657:0.012027:0.011315:0.012180:0.003425:0.012027:0.012084:0.005657:0.003425:0.011315:0.005657:0.015221:0.017260:0.008467:0.005657:0.012719:0.011315:0.012758:0.005657:0.003425:0.007043:0.005657:0.005657:0.003425:0.011315:0.012758:0.003425:0.006388
cated in the treatment of hairy cell leukae-:@0.084846:0.314800:0.475780:0.314800:0.475780:0.299044:0.084846:0.299044:0.012027:0.012719:0.006100:0.012084:0.012758:0.006129:0.003425:0.011315:0.006129:0.006100:0.011315:0.012084:0.006129:0.006100:0.005290:0.012084:0.012719:0.006100:0.017626:0.012084:0.011315:0.006100:0.006129:0.012180:0.005619:0.006129:0.011315:0.012719:0.003425:0.005369:0.009891:0.006129:0.012027:0.012084:0.003425:0.003425:0.006127:0.003425:0.012084:0.011276:0.009236:0.012719:0.012084:0.006388
mia, low-grade lymphoma, myeloma, cuta-:@0.084846:0.330490:0.475765:0.330490:0.475765:0.314734:0.084846:0.314734:0.017626:0.003425:0.012719:0.004907:0.004570:0.003425:0.012180:0.015567:0.005965:0.012527:0.005369:0.012719:0.012758:0.012084:0.004570:0.003425:0.009891:0.017626:0.012700:0.011315:0.012180:0.017626:0.012719:0.004907:0.004570:0.017626:0.009891:0.012084:0.003425:0.012180:0.017626:0.012719:0.004907:0.004580:0.012027:0.011276:0.006100:0.012719:0.006388
neous T-cell lymphoma,  as well as some :@0.084846:0.346180:0.481083:0.346180:0.481083:0.330424:0.084846:0.330424:0.011315:0.012084:0.012180:0.011276:0.007043:0.009506:0.007774:0.005965:0.012027:0.012084:0.003425:0.003425:0.009506:0.003425:0.009891:0.017626:0.012700:0.011315:0.012180:0.017626:0.012719:0.004907:0.009506:0.009506:0.012719:0.007043:0.009506:0.015567:0.012084:0.003425:0.003425:0.009506:0.012719:0.007043:0.009506:0.007043:0.012180:0.017626:0.012506:0.005330
solid tumours such as melanoma, renal cell :@0.084846:0.361870:0.481087:0.361870:0.481087:0.346114:0.084846:0.346114:0.007043:0.012180:0.003425:0.003425:0.012758:0.006494:0.006100:0.011276:0.017626:0.012180:0.011276:0.005369:0.007043:0.006494:0.007043:0.011276:0.012027:0.011315:0.006494:0.012719:0.007043:0.006494:0.017626:0.012084:0.003425:0.012719:0.011315:0.012180:0.017626:0.012719:0.004907:0.006494:0.005290:0.012084:0.011315:0.012719:0.003425:0.006494:0.012027:0.012084:0.003425:0.003852:0.005330
carcinoma and Kaposi sarcoma.:@0.084846:0.377559:0.394415:0.377559:0.394415:0.361803:0.084846:0.361803:0.012027:0.012719:0.005232:0.012027:0.003425:0.011315:0.012180:0.017626:0.012719:0.009871:0.012719:0.011315:0.012758:0.009871:0.010949:0.012719:0.012700:0.012180:0.007043:0.003425:0.009871:0.007043:0.012719:0.005234:0.012027:0.012180:0.017626:0.012719:0.005330
41,42:@0.393980:0.371914:0.420960:0.371914:0.420960:0.362728:0.393980:0.362728:0.005968:0.005968:0.002861:0.005968:0.006215
 Inter-:@0.420720:0.377533:0.475773:0.377533:0.475773:0.361777:0.420720:0.361777:0.009871:0.003925:0.011315:0.006100:0.012084:0.005369:0.006388
feron alfacon-1, IFN- 2a and IFN- 2b are re-:@0.084844:0.393222:0.475748:0.393222:0.475748:0.377466:0.084844:0.377466:0.005619:0.012084:0.005290:0.012180:0.011315:0.005378:0.012719:0.003425:0.005619:0.012719:0.012027:0.012180:0.011315:0.005965:0.010237:0.004907:0.005378:0.003925:0.008909:0.013816:0.006388:0.009200:0.010237:0.012719:0.005378:0.012719:0.011315:0.012758:0.005378:0.003925:0.008909:0.013816:0.006388:0.009217:0.010237:0.012700:0.005378:0.012719:0.005290:0.012084:0.005376:0.005290:0.012084:0.006388
α:@0.265817:0.395074:0.275881:0.395074:0.275881:0.377228:0.265817:0.377228:0.010064
α:@0.378560:0.395074:0.388624:0.395074:0.388624:0.377228:0.378560:0.377228:0.010064
combinantly produced IFNs, whereas IFN-  :@0.084844:0.408912:0.481118:0.408912:0.481118:0.393156:0.084844:0.393156:0.012027:0.012180:0.017626:0.012700:0.003425:0.011315:0.012719:0.011315:0.006100:0.003425:0.009891:0.007505:0.012700:0.005290:0.012180:0.012758:0.011276:0.012027:0.012084:0.012758:0.007505:0.003925:0.008909:0.013816:0.007043:0.004907:0.007505:0.015567:0.011315:0.012084:0.005290:0.012084:0.012719:0.007043:0.007505:0.003925:0.008909:0.013816:0.006388:0.009390:0.005330
β:@0.465975:0.410764:0.475788:0.410764:0.475788:0.392918:0.465975:0.392918:0.009814
is a human interferon produced in mamma-:@0.084844:0.424602:0.475740:0.424602:0.475740:0.408846:0.084844:0.408846:0.003425:0.007043:0.004541:0.012719:0.004541:0.011315:0.011276:0.017626:0.012719:0.011315:0.004541:0.003425:0.011315:0.006100:0.012084:0.006285:0.005619:0.012084:0.005288:0.012180:0.011315:0.004541:0.012700:0.005290:0.012180:0.012758:0.011276:0.012027:0.012084:0.012758:0.004541:0.003425:0.011315:0.004541:0.017626:0.012719:0.017626:0.017626:0.012719:0.006388
lian cells.:@0.084844:0.440292:0.163238:0.440292:0.163238:0.424536:0.084844:0.424536:0.003425:0.003425:0.012719:0.011315:0.004176:0.012027:0.012084:0.003425:0.003425:0.007043:0.005330
43-45:@0.162826:0.434658:0.190423:0.434658:0.190423:0.425472:0.162826:0.425472:0.005968:0.005968:0.003478:0.005968:0.006215
 INF-  has a greater antiprolifera-:@0.190185:0.440277:0.475775:0.440277:0.475775:0.424521:0.190185:0.424521:0.004176:0.003925:0.013816:0.008909:0.006388:0.008948:0.004176:0.011315:0.012719:0.007043:0.004176:0.012719:0.004176:0.012527:0.005290:0.012084:0.012719:0.006100:0.012084:0.005369:0.004176:0.012719:0.011315:0.006100:0.003425:0.012700:0.005288:0.012180:0.003425:0.003425:0.005619:0.012084:0.005369:0.012719:0.006388
β:@0.226977:0.442129:0.236790:0.442129:0.236790:0.424283:0.226977:0.424283:0.009814
tive effect on melanoma cells when com-:@0.084833:0.455966:0.475798:0.455966:0.475798:0.440210:0.084833:0.440210:0.006100:0.003425:0.010237:0.012084:0.007639:0.012084:0.005675:0.005619:0.012084:0.012027:0.006100:0.007639:0.012180:0.011315:0.007639:0.017626:0.012084:0.003425:0.012719:0.011315:0.012180:0.017626:0.012719:0.007639:0.012027:0.012084:0.003425:0.003425:0.007043:0.007639:0.015567:0.011315:0.012084:0.011315:0.007639:0.012027:0.012180:0.017626:0.006388
pared to INF- ; it is mainly used in the :@0.084833:0.471656:0.481109:0.471656:0.481109:0.455900:0.084833:0.455900:0.012700:0.012719:0.005290:0.012084:0.012758:0.012969:0.006100:0.012180:0.012969:0.003925:0.013816:0.008909:0.006388:0.009200:0.004907:0.012969:0.003425:0.006100:0.012969:0.003425:0.007043:0.012969:0.017626:0.012719:0.003425:0.011315:0.003425:0.009891:0.012969:0.011276:0.007043:0.012084:0.012758:0.012969:0.003425:0.011315:0.012969:0.006100:0.011315:0.012506:0.005330
α:@0.217219:0.473508:0.227283:0.473508:0.227283:0.455662:0.217219:0.455662:0.010064
treatment of multiple sclerosis.:@0.084833:0.487346:0.351721:0.487346:0.351721:0.471590:0.084833:0.471590:0.006100:0.005290:0.012084:0.012719:0.006100:0.017626:0.012084:0.011315:0.006100:0.004907:0.012180:0.005619:0.004907:0.017626:0.011276:0.003425:0.006100:0.003425:0.012700:0.003425:0.012084:0.004907:0.007043:0.012027:0.003425:0.012084:0.005290:0.012180:0.007043:0.003425:0.007043:0.005330
40,42:@0.351303:0.481716:0.378283:0.481716:0.378283:0.472530:0.351303:0.472530:0.005968:0.005968:0.002861:0.005968:0.006215
Side effects of type I INFs include::@0.084848:0.518707:0.394995:0.518707:0.394995:0.502951:0.084848:0.502951:0.009583:0.003848:0.013181:0.012508:0.005330:0.012508:0.006098:0.006042:0.012508:0.012450:0.006523:0.007466:0.005330:0.012604:0.006042:0.005330:0.006523:0.010314:0.013123:0.012508:0.005330:0.004349:0.005330:0.004349:0.014239:0.009333:0.007466:0.005330:0.003848:0.011738:0.012450:0.003848:0.011699:0.013181:0.012508:0.005330
39,40:@0.394972:0.513088:0.422940:0.513088:0.422940:0.503902:0.394972:0.503902:0.006215:0.006215:0.003107:0.006215:0.006215
 :@0.422947:0.518707:0.428277:0.518707:0.428277:0.502951:0.422947:0.502951:0.005330
n :@0.084848:0.531861:0.098177:0.531861:0.098177:0.523421:0.084848:0.523421:0.009762:0.003566
 :@0.115149:0.531861:0.118715:0.531861:0.118715:0.523421:0.115149:0.523421:0.003566
Flu-like symptoms:@0.115151:0.534981:0.275210:0.534981:0.275210:0.519225:0.115151:0.519225:0.009333:0.003848:0.011699:0.006388:0.003848:0.003848:0.009660:0.012508:0.005330:0.007466:0.010314:0.018049:0.013123:0.006523:0.012604:0.018049:0.007466
n :@0.084848:0.548135:0.098177:0.548135:0.098177:0.539695:0.084848:0.539695:0.009762:0.003566
 :@0.115149:0.548135:0.118715:0.548135:0.118715:0.539695:0.115149:0.539695:0.003566
Lethargy :@0.115151:0.551254:0.202356:0.551254:0.202356:0.535499:0.115151:0.535499:0.008890:0.012508:0.006523:0.011738:0.013143:0.005809:0.012950:0.010314:0.005330
n :@0.084848:0.564409:0.098177:0.564409:0.098177:0.555969:0.084848:0.555969:0.009762:0.003566
 :@0.115149:0.564409:0.118715:0.564409:0.118715:0.555969:0.115149:0.555969:0.003566
Auto-immune disease:@0.115151:0.567528:0.317938:0.567528:0.317938:0.551772:0.115151:0.551772:0.014239:0.011699:0.006523:0.012594:0.006388:0.003848:0.018049:0.018049:0.011699:0.011738:0.012508:0.005330:0.013181:0.003848:0.007466:0.012508:0.013143:0.007466:0.012508
n :@0.084848:0.580683:0.098177:0.580683:0.098177:0.572243:0.084848:0.572243:0.009762:0.003566
 :@0.115149:0.580683:0.118715:0.580683:0.118715:0.572243:0.115149:0.572243:0.003566
Myelosupression with neutropaenia:@0.115151:0.583802:0.442775:0.583802:0.442775:0.568046:0.115151:0.568046:0.017684:0.010314:0.012508:0.003848:0.012604:0.007466:0.011699:0.013123:0.005717:0.012508:0.007466:0.007466:0.003848:0.012604:0.011738:0.005330:0.015990:0.003848:0.006523:0.011738:0.005330:0.011738:0.012508:0.011699:0.006523:0.005696:0.012604:0.013123:0.013143:0.012508:0.011738:0.003848:0.013143
n :@0.084848:0.596957:0.098177:0.596957:0.098177:0.588517:0.084848:0.588517:0.009762:0.003566
 :@0.115149:0.596957:0.118715:0.596957:0.118715:0.588517:0.115149:0.588517:0.003566
Weight loss:@0.115151:0.600076:0.217003:0.600076:0.217003:0.584320:0.115151:0.584320:0.017570:0.012508:0.003848:0.012950:0.011738:0.006523:0.005330:0.003848:0.012604:0.007466:0.007466
n :@0.084848:0.613231:0.098177:0.613231:0.098177:0.604791:0.084848:0.604791:0.009762:0.003566
 :@0.115149:0.613231:0.118715:0.613231:0.118715:0.604791:0.115149:0.604791:0.003566
Myalgias or arthralgias:@0.115151:0.616350:0.323989:0.616350:0.323989:0.600594:0.115151:0.600594:0.017684:0.010314:0.013143:0.003848:0.012950:0.003848:0.013143:0.007466:0.005330:0.012604:0.005792:0.005330:0.013143:0.005792:0.006523:0.011738:0.005792:0.013143:0.003848:0.012950:0.003848:0.013143:0.007466
n :@0.084848:0.629505:0.098177:0.629505:0.098177:0.621065:0.084848:0.621065:0.009762:0.003566
 :@0.115149:0.629505:0.118715:0.629505:0.118715:0.621065:0.115149:0.621065:0.003566
Depression :@0.115151:0.632624:0.221770:0.632624:0.221770:0.616868:0.115151:0.616868:0.014316:0.012508:0.013123:0.005711:0.012508:0.007466:0.007466:0.003848:0.012604:0.011738:0.005330
n :@0.084848:0.645779:0.098177:0.645779:0.098177:0.637339:0.084848:0.637339:0.009762:0.003566
 :@0.115149:0.645779:0.118715:0.645779:0.118715:0.637339:0.115149:0.637339:0.003566
Pulmonary complications:@0.115151:0.648898:0.350746:0.648898:0.350746:0.633142:0.115151:0.633142:0.011392:0.011699:0.003848:0.018049:0.012604:0.011738:0.013143:0.005792:0.010314:0.005330:0.012440:0.012604:0.018049:0.013123:0.003848:0.003848:0.012450:0.013143:0.006523:0.003848:0.012604:0.011738:0.007466
n :@0.084848:0.662053:0.098177:0.662053:0.098177:0.653613:0.084848:0.653613:0.009762:0.003566
 :@0.115149:0.662053:0.118715:0.662053:0.118715:0.653613:0.115149:0.653613:0.003566
Pulmonary arterial hypertension :@0.115151:0.665172:0.414217:0.665172:0.414217:0.649416:0.115151:0.649416:0.011392:0.011699:0.003848:0.018049:0.012604:0.011738:0.013143:0.005792:0.010314:0.005330:0.013143:0.005792:0.006523:0.012508:0.005792:0.003848:0.013143:0.003848:0.005330:0.011738:0.010314:0.013123:0.012508:0.005792:0.006523:0.012508:0.011738:0.007466:0.003848:0.012604:0.011738:0.005330
Contra-indications, special  precautions :@0.103029:0.680862:0.481096:0.680862:0.481096:0.665106:0.103029:0.665106:0.015644:0.012604:0.011738:0.006523:0.005792:0.013143:0.006388:0.003848:0.011738:0.013181:0.003848:0.012450:0.013143:0.006523:0.003848:0.012604:0.011738:0.007466:0.005330:0.008986:0.007466:0.013123:0.012508:0.012450:0.003848:0.013143:0.003848:0.005330:0.003670:0.013123:0.005713:0.012508:0.012450:0.013143:0.011699:0.006523:0.003848:0.012604:0.011738:0.007466:0.005330
and drug interactions: See :@0.084845:0.696552:0.339191:0.696552:0.339191:0.680796:0.084845:0.680796:0.013143:0.011738:0.013181:0.006408:0.013181:0.005792:0.011699:0.012950:0.006408:0.003848:0.011738:0.006523:0.012508:0.005792:0.013143:0.012450:0.006523:0.003848:0.012604:0.011738:0.007466:0.005330:0.006408:0.009583:0.012508:0.012508:0.005330
MIMS Monthly, :@0.340268:0.696552:0.481084:0.696552:0.481084:0.680796:0.340268:0.680796:0.017684:0.004349:0.017684:0.009583:0.006408:0.017684:0.012604:0.011738:0.006523:0.011738:0.003848:0.010314:0.005330:0.005330
MDR:@0.084845:0.712242:0.128525:0.712242:0.128525:0.696486:0.084845:0.696486:0.017684:0.014316:0.011680
 or manufacturer’s product literature.:@0.128525:0.712242:0.473653:0.712242:0.473653:0.696486:0.128525:0.696486:0.005330:0.012604:0.005792:0.005330:0.018049:0.013143:0.011738:0.011699:0.006042:0.013143:0.012450:0.006523:0.011699:0.005694:0.012508:0.005792:0.006754:0.007466:0.005330:0.013123:0.005711:0.012604:0.013181:0.011699:0.012450:0.006523:0.005330:0.003848:0.003848:0.006523:0.012508:0.005792:0.013143:0.006523:0.011699:0.005698:0.012508:0.005330
INTERLEUKIN-2:@0.084848:0.744660:0.229380:0.744660:0.229380:0.726845:0.084848:0.726845:0.005987:0.015822:0.008980:0.011118:0.012401:0.009407:0.011118:0.013683:0.013256:0.005987:0.015822:0.008980:0.011973
Native  human  interleukin-2 (IL-2)  is  a cy-:@0.084848:0.761493:0.475758:0.761493:0.475758:0.745737:0.084848:0.745737:0.014047:0.012950:0.006331:0.003656:0.010468:0.012315:0.005330:0.004916:0.011545:0.011507:0.017857:0.012950:0.011545:0.005330:0.004916:0.003656:0.011545:0.006331:0.012315:0.005600:0.003656:0.012315:0.011507:0.009467:0.003656:0.011545:0.006196:0.010468:0.010256:0.006908:0.004156:0.008698:0.006196:0.010468:0.006908:0.005330:0.004916:0.003656:0.007274:0.005330:0.004916:0.012950:0.010256:0.012257:0.010122:0.006388
tokine-signalling molecule of the immune :@0.084848:0.777183:0.481086:0.777183:0.481086:0.761427:0.084848:0.761427:0.006331:0.012411:0.009467:0.003656:0.011545:0.012315:0.006196:0.007274:0.003656:0.012758:0.011545:0.012950:0.003656:0.003656:0.003656:0.011545:0.012758:0.009044:0.017857:0.012411:0.003656:0.012315:0.012257:0.011507:0.003656:0.012315:0.009044:0.012411:0.005850:0.009044:0.006331:0.011545:0.012315:0.009044:0.003656:0.017857:0.017857:0.011507:0.011545:0.012506:0.005330
system secreted by T-cells.  IL-2 is capable :@0.084848:0.792873:0.481060:0.792865:0.481060:0.777109:0.084848:0.777117:0.007274:0.010122:0.007274:0.006331:0.012315:0.017857:0.005667:0.007274:0.012315:0.012257:0.005519:0.012315:0.006331:0.012315:0.012989:0.005667:0.012931:0.010122:0.005667:0.008005:0.006196:0.012257:0.012315:0.003656:0.003656:0.007274:0.005330:0.012027:0.005667:0.004156:0.008698:0.006196:0.010468:0.005667:0.003656:0.007274:0.005665:0.012257:0.012950:0.012931:0.012950:0.012931:0.003656:0.012504:-0.151525
46:@0.325894:0.787246:0.338212:0.787246:0.338212:0.778060:0.325894:0.778060:0.006103:0.006215
of enhancing lymphocyte mitogenesis and :@0.084855:0.808555:0.481114:0.808555:0.481114:0.792799:0.084855:0.792799:0.012411:0.005850:0.004483:0.012315:0.011545:0.011545:0.012950:0.011545:0.012257:0.003656:0.011545:0.012758:0.004483:0.003656:0.010122:0.017857:0.012931:0.011545:0.012411:0.012257:0.010122:0.006331:0.012315:0.004483:0.017857:0.003656:0.006331:0.012411:0.012758:0.012315:0.011545:0.012315:0.007274:0.003656:0.007274:0.004483:0.012950:0.011545:0.013181:0.005330
cytotoxicity, activation of natural killer cells :@0.084855:0.824245:0.481117:0.824245:0.481117:0.808489:0.084855:0.808489:0.012257:0.010122:0.006331:0.012411:0.006331:0.012411:0.009044:0.003656:0.012257:0.003656:0.006331:0.010122:0.005138:0.005561:0.012950:0.012257:0.006331:0.003656:0.010468:0.012950:0.006331:0.003656:0.012411:0.011545:0.005561:0.012411:0.005850:0.005561:0.011545:0.012950:0.006331:0.011507:0.005600:0.012950:0.003656:0.005561:0.009467:0.003656:0.003656:0.003656:0.012315:0.005600:0.005561:0.012257:0.012315:0.003656:0.003656:0.007470:0.005330
and production of interferon-gamma.:@0.084855:0.839934:0.431474:0.839934:0.431474:0.824178:0.084855:0.824178:0.012950:0.011545:0.012989:0.005138:0.012931:0.005521:0.012411:0.012989:0.011507:0.012257:0.006331:0.003656:0.012411:0.011545:0.005138:0.012411:0.005850:0.005138:0.003656:0.011545:0.006331:0.012315:0.006515:0.005850:0.012315:0.005519:0.012411:0.011545:0.006196:0.012758:0.012950:0.017857:0.017857:0.012950:0.005330
46,47:@0.431242:0.834304:0.458760:0.834304:0.458760:0.825118:0.431242:0.825118:0.006103:0.006103:0.002995:0.006103:0.006215
 :@0.458767:0.839923:0.464098:0.839923:0.464098:0.824167:0.458767:0.824167:0.005330
Aldesleukin :@0.084848:0.872353:0.210993:0.872353:0.210993:0.854538:0.084848:0.854538:0.015822:0.005131:0.014111:0.013683:0.009407:0.005131:0.013683:0.012828:0.012401:0.005131:0.012828:0.005987
Aldesleukin (also known as proleukin) is a :@0.084848:0.889186:0.481061:0.889186:0.481061:0.873430:0.084848:0.873430:0.014239:0.003848:0.013181:0.012508:0.007466:0.003848:0.012508:0.011699:0.009660:0.003848:0.011738:0.007254:0.007100:0.013143:0.003848:0.007466:0.012604:0.007266:0.009660:0.011738:0.012604:0.015990:0.011738:0.007254:0.013143:0.007466:0.007254:0.013123:0.005715:0.012604:0.003848:0.012508:0.011699:0.009660:0.003848:0.011738:0.007100:0.007254:0.003848:0.007466:0.007254:0.013143:0.005330
recombinantly produced human IL-2 with :@0.084848:0.904875:0.481086:0.904875:0.481086:0.889119:0.084848:0.889119:0.005713:0.012508:0.012450:0.012604:0.018049:0.013123:0.003848:0.011738:0.013143:0.011738:0.006523:0.003848:0.010314:0.006523:0.013123:0.005715:0.012604:0.013181:0.011699:0.012450:0.012508:0.013181:0.006523:0.011738:0.011699:0.018049:0.013143:0.011738:0.006523:0.004349:0.008890:0.006388:0.010660:0.006523:0.015990:0.003848:0.006523:0.011738:0.005330
the same biological activities of native IL-:@0.084848:0.920565:0.475754:0.920565:0.475754:0.904809:0.084848:0.904809:0.006523:0.011738:0.012508:0.006523:0.007466:0.013143:0.018049:0.012508:0.006527:0.013123:0.003848:0.012604:0.003848:0.012604:0.012950:0.003848:0.012450:0.013143:0.003848:0.006542:0.013143:0.012450:0.006523:0.003848:0.010660:0.003848:0.006523:0.003848:0.012508:0.007480:0.006529:0.012604:0.006042:0.006525:0.011738:0.013143:0.006523:0.003848:0.010660:0.012508:0.006533:0.004349:0.008890:0.006388
2.:@0.084848:0.936255:0.100839:0.936255:0.100839:0.920499:0.084848:0.920499:0.010660:0.005330
 44,45:@0.100840:0.930625:0.131612:0.930625:0.131612:0.921439:0.100840:0.921439:0.002805:0.006215:0.006215:0.003107:0.006215:0.006215
 Aldesleukin binds to the IL-2 receptor :@0.131617:0.936244:0.481096:0.936244:0.481096:0.920488:0.131617:0.920488:0.004811:0.014239:0.003848:0.013181:0.012508:0.007466:0.003848:0.012508:0.011699:0.009660:0.003848:0.011738:0.004811:0.013123:0.003848:0.011738:0.013181:0.007466:0.004811:0.006523:0.012604:0.004801:0.006523:0.011738:0.012508:0.004801:0.004349:0.008890:0.006388:0.010660:0.004811:0.005713:0.012508:0.012450:0.012508:0.013123:0.006523:0.012604:0.005792:0.005330
and activates certain tyrosine kinase com-:@0.524239:0.079496:0.915164:0.079496:0.915164:0.063740:0.524239:0.063740:0.013143:0.011738:0.013181:0.004407:0.013143:0.012450:0.006523:0.003848:0.010660:0.013143:0.006523:0.012508:0.007466:0.004407:0.012450:0.012508:0.005792:0.006523:0.013143:0.003848:0.011738:0.004407:0.006523:0.010314:0.005711:0.012604:0.007466:0.003848:0.011738:0.012508:0.004407:0.009660:0.003848:0.011738:0.013143:0.007466:0.012508:0.004407:0.012450:0.012604:0.018049:0.006388
plexes which leads to a series of events to :@0.524239:0.095014:0.920460:0.095014:0.920460:0.079258:0.524239:0.079258:0.013123:0.003848:0.012508:0.009236:0.012508:0.007466:0.005657:0.015990:0.011738:0.003848:0.012450:0.011738:0.005657:0.003848:0.012508:0.013143:0.013181:0.007466:0.005657:0.006523:0.012604:0.005657:0.013143:0.005657:0.007466:0.012508:0.005792:0.003848:0.012508:0.007466:0.005657:0.012604:0.006042:0.005657:0.012508:0.010660:0.012508:0.011738:0.006523:0.007466:0.005657:0.006523:0.012604:0.005330
activate the cellular immune system to kill :@0.524239:0.110532:0.920475:0.110532:0.920475:0.094776:0.524239:0.094776:0.013143:0.012450:0.006523:0.003848:0.010660:0.013143:0.006523:0.012508:0.005946:0.006523:0.011738:0.012508:0.005934:0.012450:0.012508:0.003848:0.003848:0.011699:0.003848:0.013143:0.005792:0.005946:0.003848:0.018049:0.018049:0.011699:0.011738:0.012508:0.005946:0.007466:0.010314:0.007466:0.006523:0.012508:0.018049:0.005946:0.006523:0.012604:0.005934:0.009660:0.003848:0.003848:0.003848:0.005330
tumour cells.:@0.524239:0.126050:0.641387:0.126050:0.641387:0.110294:0.524239:0.110294:0.006523:0.011699:0.018049:0.012604:0.011699:0.005792:0.005330:0.012450:0.012508:0.003848:0.003848:0.007466:0.005330
46,47:@0.641378:0.120448:0.669346:0.120448:0.669346:0.111262:0.641378:0.111262:0.006215:0.006215:0.003107:0.006215:0.006215
 :@0.669353:0.126067:0.674683:0.126067:0.674683:0.110311:0.669353:0.110311:0.005330
Aldesleukin is indicated for the treatment :@0.542430:0.141585:0.920539:0.141585:0.920539:0.125829:0.542430:0.125829:0.014028:0.003637:0.012969:0.012296:0.007254:0.003637:0.012296:0.011488:0.009448:0.003637:0.011526:0.005138:0.003637:0.007254:0.005138:0.003637:0.011526:0.012969:0.003637:0.012238:0.012931:0.006312:0.012296:0.012969:0.005138:0.005830:0.012392:0.005580:0.005138:0.006312:0.011526:0.012296:0.005138:0.006312:0.005501:0.012296:0.012931:0.006312:0.017838:0.012296:0.011526:0.006521:0.005330
of metastatic renal cell carcinoma and :@0.524246:0.157103:0.920483:0.157103:0.920483:0.141347:0.524246:0.141347:0.012392:0.005830:0.011622:0.017838:0.012296:0.006312:0.012931:0.007254:0.006312:0.012931:0.006312:0.003637:0.012238:0.011622:0.005501:0.012296:0.011526:0.012931:0.003637:0.011622:0.012238:0.012296:0.003637:0.003637:0.011622:0.012238:0.012931:0.005446:0.012238:0.003637:0.011526:0.012392:0.017838:0.012931:0.011622:0.012931:0.011526:0.013181:0.005330
melanoma.:@0.524246:0.172620:0.630964:0.172620:0.630964:0.156865:0.524246:0.156865:0.017838:0.012296:0.003637:0.012931:0.011526:0.012392:0.017838:0.012931:0.005330
47,107:@0.630744:0.167016:0.664310:0.167016:0.664310:0.157830:0.630744:0.157830:0.006092:0.006092:0.002984:0.006092:0.006092:0.006215
 :@0.664319:0.172635:0.669649:0.172635:0.669649:0.156879:0.664319:0.156879:0.005330
The side effects of aldesleukin include::@0.524234:0.203684:0.880611:0.203684:0.880611:0.187928:0.524234:0.187928:0.008197:0.011738:0.012508:0.005330:0.007466:0.003848:0.013181:0.012508:0.005330:0.012508:0.006088:0.006042:0.012508:0.012450:0.006523:0.007466:0.005330:0.012604:0.006042:0.005330:0.013143:0.003848:0.013181:0.012508:0.007466:0.003848:0.012508:0.011699:0.009660:0.003848:0.011738:0.005330:0.003848:0.011738:0.012450:0.003848:0.011699:0.013181:0.012508:0.005330
47:@0.880612:0.198061:0.893042:0.198061:0.893042:0.188876:0.880612:0.188876:0.006215:0.006215
n :@0.524242:0.216672:0.537570:0.216672:0.537570:0.208232:0.524242:0.208232:0.009762:0.003566
 :@0.554542:0.216672:0.558108:0.216672:0.558108:0.208232:0.554542:0.208232:0.003566
Flu-like symptoms:@0.554545:0.219791:0.714603:0.219791:0.714603:0.204035:0.554545:0.204035:0.009333:0.003848:0.011699:0.006388:0.003848:0.003848:0.009660:0.012508:0.005330:0.007466:0.010314:0.018049:0.013123:0.006523:0.012604:0.018049:0.007466
n :@0.524242:0.232782:0.537570:0.232782:0.537570:0.224342:0.524242:0.224342:0.009762:0.003566
 :@0.554542:0.232782:0.558108:0.232782:0.558108:0.224342:0.554542:0.224342:0.003566
Asthenia :@0.554545:0.235901:0.641078:0.235901:0.641078:0.220146:0.554545:0.220146:0.014239:0.007466:0.006523:0.011738:0.012508:0.011738:0.003848:0.013143:0.005330
n :@0.524242:0.248893:0.537570:0.248893:0.537570:0.240453:0.524242:0.240453:0.009762:0.003566
 :@0.554542:0.248893:0.558108:0.248893:0.558108:0.240453:0.554542:0.240453:0.003566
Pain :@0.554545:0.252012:0.599995:0.252012:0.599995:0.236256:0.554545:0.236256:0.011392:0.013143:0.003848:0.011738:0.005330
n :@0.524242:0.265004:0.537570:0.265004:0.537570:0.256563:0.524242:0.256563:0.009762:0.003566
 :@0.554542:0.265004:0.558108:0.265004:0.558108:0.256563:0.554542:0.256563:0.003566
Hypotension and tachycardia:@0.554545:0.268123:0.834470:0.268123:0.834470:0.252367:0.554545:0.252367:0.013143:0.010314:0.013123:0.012604:0.006523:0.012508:0.011738:0.007466:0.003848:0.012604:0.011726:0.005330:0.013143:0.011738:0.013181:0.005330:0.006523:0.013143:0.012450:0.011738:0.010314:0.012450:0.013143:0.005675:0.013181:0.003848:0.013143
n :@0.524242:0.281114:0.537570:0.281114:0.537570:0.272674:0.524242:0.272674:0.009762:0.003566
 :@0.554542:0.281114:0.558108:0.281114:0.558108:0.272674:0.554542:0.272674:0.003566
Confusion :@0.554545:0.284233:0.653258:0.284233:0.653258:0.268477:0.554545:0.268477:0.015644:0.012604:0.011738:0.006042:0.011699:0.007466:0.003848:0.012604:0.011738:0.005330
n :@0.524242:0.297225:0.537570:0.297225:0.537570:0.288785:0.524242:0.288785:0.009762:0.003566
 :@0.554542:0.297225:0.558108:0.297225:0.558108:0.288785:0.554542:0.288785:0.003566
Bilirubinaemia and an increase in :@0.554545:0.300344:0.868571:0.300344:0.868571:0.284588:0.554545:0.284588:0.011045:0.003848:0.003848:0.003848:0.005792:0.011699:0.013123:0.003848:0.011738:0.013143:0.012508:0.018049:0.003848:0.013143:0.005330:0.013143:0.011738:0.013181:0.005330:0.013143:0.011738:0.005330:0.003848:0.011738:0.012450:0.005705:0.012508:0.013143:0.007466:0.012508:0.005330:0.003848:0.011738:0.005330
creatinine levels:@0.554545:0.315862:0.704730:0.315862:0.704730:0.300106:0.554545:0.300106:0.012450:0.005713:0.012508:0.013143:0.006523:0.003848:0.011738:0.003848:0.011738:0.012508:0.005330:0.003848:0.012508:0.010660:0.012508:0.003848:0.007466
n :@0.524242:0.328858:0.537570:0.328858:0.537570:0.320418:0.524242:0.320418:0.009762:0.003566
 :@0.554542:0.328858:0.558108:0.328858:0.558108:0.320418:0.554542:0.320418:0.003566
Peripheral oedema:@0.554545:0.331977:0.735548:0.331977:0.735548:0.316221:0.554545:0.316221:0.011392:0.012508:0.005792:0.003848:0.013123:0.011738:0.012508:0.005792:0.013143:0.003848:0.005330:0.012594:0.012508:0.013181:0.012508:0.018049:0.013143
n :@0.524242:0.344969:0.537570:0.344969:0.537570:0.336529:0.524242:0.336529:0.009762:0.003566
 :@0.554542:0.344969:0.558108:0.344969:0.558108:0.336529:0.554542:0.336529:0.003566
Nausea and vomiting:@0.554545:0.348088:0.755686:0.348088:0.755686:0.332332:0.554545:0.332332:0.014239:0.013143:0.011699:0.007466:0.012508:0.013143:0.005330:0.013143:0.011738:0.013181:0.005330:0.010660:0.012604:0.018049:0.003848:0.006523:0.003848:0.011738:0.012950
n :@0.524242:0.361079:0.537570:0.361079:0.537570:0.352639:0.524242:0.352639:0.009762:0.003566
 :@0.554542:0.361079:0.558108:0.361079:0.558108:0.352639:0.554542:0.352639:0.003566
Diarrhoea :@0.554545:0.364198:0.653308:0.364198:0.653308:0.348443:0.554545:0.348443:0.014316:0.003848:0.013143:0.005792:0.006342:0.011738:0.012604:0.012508:0.013143:0.005330
n :@0.524242:0.377190:0.537570:0.377190:0.537570:0.368750:0.524242:0.368750:0.009762:0.003566
 :@0.554542:0.377190:0.558108:0.377190:0.558108:0.368750:0.554542:0.368750:0.003566
Respiratory effects:@0.554545:0.380309:0.726250:0.380309:0.726250:0.364553:0.554545:0.364553:0.011680:0.012508:0.007466:0.013123:0.003848:0.005792:0.013143:0.006523:0.012604:0.005792:0.010314:0.005321:0.012508:0.006096:0.006042:0.012508:0.012450:0.006523:0.007466
n :@0.524242:0.393301:0.537570:0.393301:0.537570:0.384860:0.524242:0.384860:0.009762:0.003566
 :@0.554542:0.393301:0.558108:0.393301:0.558108:0.384860:0.554542:0.384860:0.003566
Rash :@0.554545:0.396420:0.603902:0.396420:0.603902:0.380664:0.554545:0.380664:0.011680:0.013143:0.007466:0.011738:0.005330
n :@0.524242:0.409411:0.537570:0.409411:0.537570:0.400971:0.524242:0.400971:0.009762:0.003566
 :@0.554542:0.409411:0.558108:0.409411:0.558108:0.400971:0.554542:0.400971:0.003566
Thrombocytopaenia and anaemia:@0.554545:0.412531:0.880255:0.412531:0.880255:0.396775:0.554545:0.396775:0.008197:0.011738:0.005709:0.012604:0.018049:0.013123:0.012604:0.012450:0.010314:0.006523:0.012604:0.013123:0.013143:0.012508:0.011738:0.003848:0.013143:0.005330:0.013143:0.011738:0.013181:0.005330:0.013143:0.011738:0.013143:0.012508:0.018049:0.003848:0.013143
n :@0.524242:0.425522:0.537570:0.425522:0.537570:0.417082:0.524242:0.417082:0.009762:0.003566
 :@0.554542:0.425522:0.558108:0.425522:0.558108:0.417082:0.554542:0.417082:0.003566
Oliguria :@0.554545:0.428641:0.631726:0.428641:0.631726:0.412885:0.554545:0.412885:0.016722:0.003848:0.003848:0.012950:0.011699:0.005792:0.003848:0.013143:0.005330
Contra-indications, special  precautions :@0.542422:0.444159:0.920489:0.444159:0.920489:0.428403:0.542422:0.428403:0.015644:0.012604:0.011738:0.006523:0.005792:0.013143:0.006388:0.003848:0.011738:0.013181:0.003848:0.012450:0.013143:0.006523:0.003848:0.012604:0.011738:0.007466:0.005330:0.008986:0.007466:0.013123:0.012508:0.012450:0.003848:0.013143:0.003848:0.005330:0.003670:0.013123:0.005713:0.012508:0.012450:0.013143:0.011699:0.006523:0.003848:0.012604:0.011738:0.007466:0.005330
and drug interactions: See :@0.524238:0.459677:0.778594:0.459677:0.778594:0.443921:0.524238:0.443921:0.013143:0.011738:0.013181:0.006413:0.013181:0.005792:0.011699:0.012950:0.006410:0.003848:0.011738:0.006523:0.012508:0.005792:0.013143:0.012450:0.006523:0.003848:0.012604:0.011738:0.007466:0.005330:0.006410:0.009583:0.012508:0.012508:0.005330
MIMS Monthly, :@0.779662:0.459677:0.920478:0.459677:0.920478:0.443921:0.779662:0.443921:0.017684:0.004349:0.017684:0.009583:0.006408:0.017684:0.012604:0.011738:0.006523:0.011738:0.003848:0.010314:0.005330:0.005330
MDR:@0.524238:0.475194:0.567918:0.475194:0.567918:0.459438:0.524238:0.459438:0.017684:0.014316:0.011680
 or manufacturer’s product literature.:@0.567918:0.475194:0.913046:0.475194:0.913046:0.459438:0.567918:0.459438:0.005330:0.012604:0.005792:0.005330:0.018049:0.013143:0.011738:0.011699:0.006042:0.013143:0.012450:0.006523:0.011699:0.005694:0.012508:0.005792:0.006754:0.007466:0.005330:0.013123:0.005711:0.012604:0.013181:0.011699:0.012450:0.006523:0.005330:0.003848:0.003848:0.006523:0.012508:0.005792:0.013143:0.006523:0.011699:0.005698:0.012508:0.005330
OTHERS:@0.524242:0.507313:0.600356:0.507313:0.600356:0.489498:0.524242:0.489498:0.017960:0.008980:0.014539:0.011118:0.012401:0.011118
Pazopanib:@0.524242:0.525040:0.634137:0.525040:0.634137:0.507225:0.524242:0.507225:0.011973:0.014111:0.009835:0.013683:0.014111:0.014111:0.012828:0.005131:0.014111
Pazopanib  is a  kinase inhibitor  indicated :@0.524242:0.541710:0.920485:0.541710:0.920485:0.525954:0.524242:0.525954:0.011392:0.013143:0.008178:0.012604:0.013123:0.013143:0.011738:0.003848:0.013123:0.005330:0.003529:0.003848:0.007466:0.008871:0.013143:0.005330:0.003531:0.009660:0.003848:0.011738:0.013143:0.007466:0.012508:0.008871:0.003848:0.011738:0.011738:0.003848:0.013123:0.003848:0.006523:0.012604:0.005792:0.005330:0.003527:0.003848:0.011738:0.013181:0.003848:0.012450:0.013143:0.006523:0.012508:0.013181:0.005330
for the treatment of patients with ad-:@0.524242:0.557227:0.915167:0.557227:0.915167:0.541471:0.524242:0.541471:0.006042:0.012604:0.005792:0.013027:0.006523:0.011738:0.012508:0.013027:0.006523:0.005711:0.012508:0.013143:0.006523:0.018049:0.012508:0.011738:0.006523:0.013027:0.012604:0.006042:0.013027:0.013123:0.013143:0.006523:0.003848:0.012508:0.011738:0.006523:0.007466:0.013027:0.015990:0.003848:0.006523:0.011738:0.013027:0.013143:0.013181:0.006388
vanced renal cell carcinoma and ad-:@0.524242:0.572745:0.915169:0.572745:0.915169:0.556989:0.524242:0.556989:0.010660:0.013143:0.011738:0.012450:0.012508:0.013181:0.012758:0.005713:0.012508:0.011738:0.013143:0.003848:0.012758:0.012450:0.012508:0.003848:0.003848:0.012758:0.012450:0.013143:0.005657:0.012450:0.003848:0.011738:0.012604:0.018049:0.013143:0.012758:0.013143:0.011738:0.013181:0.012758:0.013143:0.013181:0.006388
vanced soft tissue sarcoma who have re-:@0.524242:0.588263:0.915165:0.588263:0.915165:0.572507:0.524242:0.572507:0.010660:0.013143:0.011738:0.012450:0.012508:0.013181:0.006600:0.007466:0.012604:0.006042:0.006523:0.006600:0.006523:0.003848:0.007466:0.007466:0.011699:0.012508:0.006600:0.007466:0.013143:0.005663:0.012450:0.012604:0.018049:0.013143:0.006600:0.015990:0.011738:0.012604:0.006591:0.011738:0.013143:0.010660:0.012508:0.006600:0.005713:0.012508:0.006388
ceived prior chemotherapy.:@0.524242:0.603781:0.843839:0.603781:0.843839:0.588025:0.524242:0.588025:0.013989:0.014047:0.005388:0.012200:0.014047:0.014720:0.016029:0.014663:0.007331:0.005388:0.014143:0.007331:0.016029:0.013989:0.013277:0.014047:0.019589:0.014143:0.008063:0.013277:0.014047:0.007331:0.014682:0.014663:0.011853:0.005330
116:@0.845349:0.598181:0.865789:0.598181:0.865789:0.588996:0.845349:0.588996:0.007112:0.007112:0.006215
 The :@0.866693:0.603800:0.920495:0.603800:0.920495:0.588044:0.866693:0.588044:0.016029:0.008197:0.011738:0.012508:0.005330
efficacy of pazopanib for the treatment of :@0.524236:0.619318:0.920478:0.619318:0.920478:0.603562:0.524236:0.603562:0.012508:0.006042:0.004686:0.004686:0.012450:0.013143:0.012450:0.010314:0.004483:0.012604:0.006042:0.004482:0.013123:0.013143:0.008178:0.012604:0.013123:0.013143:0.011738:0.003848:0.013123:0.004489:0.006042:0.012604:0.005792:0.004478:0.006523:0.011738:0.012508:0.004480:0.006523:0.005711:0.012508:0.013143:0.006523:0.018049:0.012508:0.011738:0.006523:0.004476:0.012604:0.006042:0.005330
patients with adipocytic soft tissue sarco-:@0.524236:0.634836:0.915122:0.634836:0.915122:0.619080:0.524236:0.619080:0.013123:0.013143:0.006523:0.003848:0.012508:0.011738:0.006523:0.007466:0.007312:0.015990:0.003848:0.006523:0.011738:0.007312:0.013143:0.013181:0.003848:0.013123:0.012604:0.012450:0.010314:0.006523:0.003848:0.012450:0.007312:0.007466:0.012604:0.006042:0.006523:0.007312:0.006523:0.003848:0.007466:0.007466:0.011699:0.012508:0.007324:0.007466:0.013143:0.005661:0.012450:0.012604:0.006388
ma or gastro-intestinal stromal tumours has :@0.524236:0.650354:0.920483:0.650354:0.920483:0.634598:0.524236:0.634598:0.018049:0.013143:0.004368:0.012604:0.005792:0.004368:0.012950:0.013143:0.007466:0.006523:0.005717:0.012604:0.006388:0.003848:0.011738:0.006523:0.012508:0.007466:0.006523:0.003848:0.011738:0.013143:0.003848:0.004368:0.007466:0.006523:0.005713:0.012604:0.018049:0.013143:0.003848:0.004368:0.006523:0.011699:0.018049:0.012604:0.011699:0.005792:0.007466:0.004356:0.011738:0.013143:0.007466:0.005330
not been demonstrated.:@0.524236:0.665871:0.754183:0.665871:0.754183:0.650115:0.524236:0.650115:0.011738:0.012604:0.006523:0.005330:0.013123:0.012508:0.012508:0.011738:0.005330:0.013181:0.012508:0.018049:0.012604:0.011738:0.007466:0.006523:0.005792:0.013143:0.006523:0.012508:0.013181:0.005330
MONOCLONAL ANTIBODIES:@0.524242:0.697994:0.806464:0.697994:0.806464:0.680179:0.524242:0.680179:0.019242:0.017960:0.015822:0.017960:0.016677:0.009407:0.017960:0.015822:0.015822:0.009407:0.005987:0.015822:0.015822:0.008980:0.005987:0.012401:0.017960:0.014966:0.005987:0.011118:0.011118
Monoclonal  antibodies (MAbs) are bio-:@0.524242:0.714664:0.915155:0.714664:0.915155:0.698908:0.524242:0.698908:0.017684:0.012604:0.011738:0.012604:0.012450:0.003848:0.012604:0.011738:0.013143:0.003848:0.005330:0.006315:0.013143:0.011738:0.006523:0.003848:0.013123:0.012604:0.013181:0.003848:0.012508:0.007466:0.011661:0.007100:0.017684:0.014239:0.013123:0.007466:0.007100:0.011661:0.013143:0.005715:0.012508:0.011661:0.013123:0.003848:0.012604:0.006388
logical agents that usually target specific :@0.524242:0.730181:0.920478:0.730181:0.920478:0.714426:0.524242:0.714426:0.003848:0.012604:0.012950:0.003848:0.012450:0.013143:0.003848:0.007060:0.013143:0.012950:0.012508:0.011738:0.006523:0.007466:0.007050:0.006523:0.011738:0.013143:0.006523:0.007048:0.011699:0.007466:0.011699:0.013143:0.003848:0.003848:0.010314:0.007066:0.006523:0.013143:0.005807:0.012950:0.012508:0.006523:0.007047:0.007466:0.013123:0.012508:0.012450:0.003848:0.004686:0.004686:0.012450:0.005330
antigens which are highly expressed on :@0.524242:0.745699:0.920481:0.745699:0.920481:0.729943:0.524242:0.729943:0.013143:0.011738:0.006523:0.003848:0.012950:0.012508:0.011738:0.007466:0.010275:0.015990:0.011738:0.003848:0.012450:0.011738:0.010275:0.013143:0.005715:0.012508:0.010275:0.011738:0.003848:0.012950:0.011738:0.003848:0.010314:0.010275:0.012508:0.009236:0.013123:0.005715:0.012508:0.007466:0.007466:0.012508:0.013181:0.010275:0.012604:0.011738:0.005330
cancer cells, but not on normal cells.:@0.524242:0.761217:0.867420:0.761217:0.867420:0.745461:0.524242:0.745461:0.012450:0.013143:0.011738:0.012450:0.012508:0.005792:0.005330:0.012450:0.012508:0.003848:0.003848:0.007466:0.005330:0.005330:0.013123:0.011699:0.006523:0.005330:0.011738:0.012604:0.006523:0.005330:0.012604:0.011738:0.005330:0.011738:0.012604:0.006283:0.018049:0.013143:0.003848:0.005330:0.012450:0.012508:0.003848:0.003848:0.007466:0.005330
48:@0.867429:0.755613:0.879859:0.755613:0.879859:0.746427:0.867429:0.746427:0.006215:0.006215
MAbs are subdivided into naked or con-:@0.542424:0.776754:0.915176:0.776754:0.915176:0.760998:0.542424:0.760998:0.017684:0.014239:0.013123:0.007466:0.004945:0.013143:0.005715:0.012508:0.004945:0.007466:0.011699:0.013123:0.013181:0.003848:0.010660:0.003848:0.013181:0.012508:0.013181:0.004957:0.003848:0.011738:0.006523:0.012604:0.004936:0.011738:0.013143:0.009660:0.012508:0.013181:0.004945:0.012604:0.005792:0.004932:0.012450:0.012604:0.011738:0.006388
jugated MAbs.  :@0.524239:0.792272:0.679080:0.792277:0.679080:0.776521:0.524239:0.776516:0.003906:0.011699:0.012950:0.013143:0.006523:0.012508:0.013181:0.005330:0.017684:0.014239:0.013123:0.007466:0.005330:0.012428:-0.348690
39:@0.661316:0.786658:0.673746:0.786658:0.673746:0.777472:0.661316:0.777472:0.006215:0.006215
Naked MAbs are not attached to any :@0.542421:0.807795:0.920476:0.807795:0.920476:0.792039:0.542421:0.792039:0.014239:0.013143:0.009660:0.012508:0.013181:0.008621:0.017684:0.014239:0.013123:0.007466:0.008621:0.013143:0.005715:0.012508:0.008621:0.011738:0.012604:0.006523:0.008621:0.013143:0.006523:0.006523:0.013143:0.012450:0.011738:0.012508:0.013181:0.008621:0.006523:0.012604:0.008621:0.013143:0.011738:0.010314:0.005330
drug  or radio-active material, whereas :@0.524237:0.823313:0.920480:0.823313:0.920480:0.807557:0.524237:0.807557:0.013181:0.005792:0.011699:0.012950:0.005330:0.008053:0.012604:0.005792:0.013393:0.005792:0.013143:0.013181:0.003848:0.012604:0.006388:0.013143:0.012450:0.006523:0.003848:0.010660:0.012508:0.013393:0.018049:0.013143:0.006523:0.012508:0.005792:0.003848:0.013143:0.003848:0.005330:0.013393:0.015990:0.011738:0.012508:0.005709:0.012508:0.013143:0.007466:0.005330
conjugated MAbs are joined to a toxin or :@0.524237:0.838830:0.920484:0.838830:0.920484:0.823074:0.524237:0.823074:0.012450:0.012604:0.011738:0.003906:0.011699:0.012950:0.013143:0.006523:0.012508:0.013181:0.006269:0.017684:0.014239:0.013123:0.007466:0.006281:0.013143:0.005715:0.012508:0.006279:0.003906:0.012604:0.003848:0.011738:0.012508:0.013181:0.006279:0.006523:0.012604:0.006273:0.013143:0.006283:0.006523:0.012604:0.009236:0.003848:0.011738:0.006275:0.012604:0.005792:0.005330
radio-active isotope.:@0.524237:0.854348:0.717661:0.854348:0.717661:0.838592:0.524237:0.838592:0.005792:0.013143:0.013181:0.003848:0.012604:0.006388:0.013143:0.012450:0.006523:0.003848:0.010660:0.012508:0.005330:0.003848:0.007466:0.012604:0.006523:0.012604:0.013123:0.012508:0.005330
39:@0.717662:0.848749:0.730092:0.848749:0.730092:0.839563:0.717662:0.839563:0.006215:0.006215
Naked MAbs:@0.524242:0.886471:0.658939:0.886471:0.658939:0.868656:0.524242:0.868656:0.015822:0.014111:0.012401:0.013683:0.014111:0.005987:0.019242:0.015822:0.014111:0.009407
Alemtuzumab:@0.524242:0.902581:0.669201:0.902581:0.669201:0.884560:0.524242:0.884560:0.015822:0.005131:0.013683:0.020098:0.006414:0.012828:0.009835:0.012828:0.020098:0.014111:0.014111
Alemtuzumab is a humanised MAb direct-:@0.524242:0.920721:0.915153:0.920721:0.915153:0.904965:0.524242:0.904965:0.014239:0.003848:0.012508:0.018049:0.006523:0.011699:0.008178:0.011699:0.018049:0.013143:0.013123:0.005272:0.003848:0.007466:0.005272:0.013143:0.005272:0.011738:0.011699:0.018049:0.013143:0.011738:0.003848:0.007466:0.012508:0.013181:0.005272:0.017684:0.014239:0.013123:0.005272:0.013181:0.003848:0.005717:0.012508:0.012450:0.006523:0.006388
ed against the glycoprotein CD52,  a :@0.524242:0.936239:0.920474:0.936239:0.920474:0.920483:0.524242:0.920483:0.012508:0.013181:0.015529:0.013143:0.012950:0.013143:0.003848:0.011738:0.007466:0.006523:0.015529:0.006523:0.011738:0.012508:0.015529:0.012950:0.003848:0.010314:0.012450:0.012604:0.013123:0.005713:0.012604:0.006523:0.012508:0.003848:0.011738:0.015529:0.015644:0.014316:0.010660:0.010660:0.005330:0.005330:0.010212:0.013143:0.005330
DRUG-CLASS OVERVIEW:@0.084848:0.038601:0.357590:0.038601:0.357590:0.019343:0.084848:0.019343:0.017498:0.014276:0.015405:0.020508:0.007808:0.019121:0.010866:0.017404:0.011712:0.011712:0.006515:0.020438:0.016510:0.012606:0.013356:0.016510:0.005315:0.012606:0.022578